BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/18/2014 7:49:00 PM | Browse: 1172 | Download: 1574
 |
Received |
|
2013-10-26 12:33 |
 |
Peer-Review Started |
|
2013-10-27 12:45 |
 |
To Make the First Decision |
|
2013-12-04 08:29 |
 |
Return for Revision |
|
2013-12-04 16:38 |
 |
Revised |
|
2013-12-26 00:04 |
 |
Second Decision |
|
2014-05-29 20:19 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2014-05-29 20:52 |
 |
Articles in Press |
|
2014-05-29 21:03 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-08-28 15:07 |
 |
Publish the Manuscript Online |
|
2014-09-18 19:50 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Propofol sedation during endoscopic treatment for early gastric cancer compared to midazolam
|
Manuscript Source |
Invited Manuscript |
All Author List |
Shinsuke Kiriyama, Hiroshi Naitoh and Hiroyuki Kuwano |
Funding Agency and Grant Number |
|
Corresponding Author |
Shinsuke Kiriyama, MD, PhD, Department of Surgery, Gunma Chuo General Hospital, Maebashi, 1-7-13, Koun-cho, Mebashi, Gunma 371-0025, Japan. drkiriyama@yahoo.co.jp |
Key Words |
Sedation; Gastric cancer; Endoscopic submucosal dissection; Endoscopic resection; Propofol |
Core Tip |
According to the literature, endoscopic submucosal dissection (ESD) has been proposed as the gold standard in the treatment of early gastric cancer. However, ESD requires safe sedation management. This review covers safe sedation using propofol and other sedative drugs in the context of the available literature. Moreover, understanding safe sedation could be important in managing perioperative patients with gastric ESD. To this end, we suggest that sedation using propofol is safe and results in patient satisfaction after endoscopic gastric treatment for ESD. |
Publish Date |
2014-09-18 19:50 |
Citation |
Kiriyama S, Naitoh H, Kuwano H. Propofol sedation during endoscopic treatment for early gastric cancer compared to midazolam. World J Gastroenterol 2014; 20(34): 11985-11990 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i34/11985.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i34.11985 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345